TPD & Induced Proximity Summit Leaderboard
  • Friday, July 31, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 789

Author

Pharma Journalist 8969 posts 0 comments

Omron Healthcare Launches Avail enabling drug-free pain relief

Jan 10, 2018
Omron Healthcare introduces an over the counter medical device, Avail for effective drug-free pain relief as millions of Americans suffer from alarming chronic pain Avail is Omron's…
Read More...

Cofactor Genomics declares results from Fred Hutchinson Cancer Research Center

Jan 10, 2018
Cofactor Genomics declared the results from a study undertaken by them and Fred Hutchinson Cancer Research Center slated for presentation at the Molecular Medicine Tri-Conference in…
Read More...

TPC declares Strategic agreement with Vizient

Jan 10, 2018
The network of independent health systems based out of Arkansas, Missouri and Texas collaborate with Vizient for comprehensive sourcing, improvement of performance as well as services…
Read More...

U.S. FDA enlists Clearbridge Biomedic’s ClearCell FX1 system

Jan 10, 2018
Clearbridge Biomedics announced successful registration of ClearCell® FX1 system, its target cell- enrichment device with the U.S FDA as a class I Medical device for to diagnose…
Read More...

Cepheid granted FDA clearance for Xpert Xpress Flu test

Jan 10, 2018
Cepheid declared that clearance has been granted by US FDA 510 (K) waiving clinical laboratory improvement Amendments CLIA for Xpert Xpress Flu test. Performed in near-patient settings,…
Read More...

GT Biopharma completes dosing in Phase 1 Clinical Trial for GTP-004 to treat Myasthenia Gravis

Jan 10, 2018
GT Biopharma announces the successful completion of dosing in its phase 1 clinical trial for GTP-004 that claims to treat Myasthenia gravis. GTP-004 ensures safe administration of…
Read More...

Wuxi NextCode partners with Rhythm to treat rare Obesity Genetic Disorders

Jan 10, 2018
Global standard platform for genomic data, Wuxi NextCode announced partnering with Rhythm to develop and commercialize therapies aimed to treat rare genetic disorders of obesity. Rhythm…
Read More...

Emotional Brain declares successful Phase 2B trials for FSIAD products Lybrido and Lybridos

Jan 10, 2018
Emotional Brain finally declares the successful Phase 2B results for its products Lybrido and Lybridos that were tested in 497 women suffering from Female sexual interest and Arousal…
Read More...

Aerin to rollout VIVAER for overcoming nasal airway obstruction

Jan 10, 2018
It is to be taken into account that Aerin Medical has been granted clearance for its novel non-invasive Airway Remodeling System termed as VIVAER to overcome nasal airway barriers thus…
Read More...

Novo Nordisk Tries disposal program for patients in California

Jan 9, 2018
NovoNordisk pilots an education and disposal program for Californian patients to purge sharp products to safely use the company’s medicines that are otherwise delivered by a syringe or…
Read More...
Prev Next
2nd Obesity & Weight Loss Drug Development Summit Europe
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
Neuropsychiatric Drug Development Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Raw Materials for Cell & Gene Therapy Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • From Innovation to Acquisition: CrossBridge Bio’s ADC Journey
  • COPD Foundations Joins the COPD Drug Development Summit
  • argenx to Acquire Forte Biosciences in $2.2 Billion Deal
  • BioMarin, n-Lorem Join Forces on ReNU Syndrome Therapy
  • Pfizer, Eisai Partner to Co-Promote Nurtec in Japan

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

From Innovation to Acquisition: CrossBridge Bio’s ADC…

COPD Foundations Joins the COPD Drug Development Summit

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.